Magnetic resonance imaging-based volumetry differentiates idiopathic Parkinson's syndrome from multiple system atrophy and progressive supranuclear palsy

Annals of Neurology

Volumn 45, Issue 1, 1999, Pages 65-74

  Schulz, Jörg B ^a   Skalej, Martin ^a   Wedekind, Dirk ^a   Luft, Andreas R ^a   Abele, Michael ^a   Voigt, Karsten ^a   Dichgans, Johannes ^a   Klockgether, Thomas ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BRAIN SIZE; BRAIN STEM; CAUDATE NUCLEUS; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; DISCRIMINANT ANALYSIS; FEMALE; HUMAN; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSON DISEASE; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; PUTAMEN; SHY DRAGER SYNDROME; VOLUMETRY;

ADULT; AGED; ATROPHY; BRAIN STEM; CAUDATE NUCLEUS; CEREBELLUM; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MULTIPLE SYSTEM ATROPHY; PARKINSON DISEASE, SECONDARY; PUTAMEN; SUPRANUCLEAR PALSY, PROGRESSIVE;

EID: 0032925853     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/1531-8249(199901)45:1<65::AID-ART12>3.0.CO;2-1     Document Type: Article

References (42)

1. Koller WC, Montgomery EB. Issues in the early diagnosis of Parkinson's disease. Neurology 1997;49(Suppl 1):S10-S25
2. 18F-dopa PET data. J Neurol Neurosurg Psychiatry 1994; 57:278-284
3. Brooks DJ. Functional imaging of movement disorders. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994:65-87
4. Leenders KL, Frackowiak RS, Lees AJ. Steele-Richardson-Olszewski syndrome. Brain energy metabolism, blood flow and fluorodopa uptake measured by positron emission tomography. Brain 1988;111:615-630
5. 11C-raclopride and positron emission tomography. Ann Neurol 1992;31:184-192
6. 123IBZM-SPECT. J Neurol Neurosurg Psychiatry 1994;57:1047-1056
7. 123I-IBZM single photon emission computed tomography. Arch Neurol 1993;50:513-516
8. 123I-Iodobenzamide-SPECT predicts dopaminergic responsiveness in patients with de novo parkinsonism. Neurology 1992;42:556-561
9. 2 receptor imaging with SPECT: studies in different neuropsychiatric disorders. J Cereb Blood Flow Metab 1991;11:220-228
10. Davie CA, Wenning GK, Barker GJ, et al. Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Ann Neurol 1995; 37:204-210
11. Luft AR, Skalej M, Weite D, Kolb R. Reliability and exactness ot MRI-based volumetry: a phantom study. J Magn Reson Imaging 1996;6:700-704
12. Luft AR, Skalej M, Welte D, et al. A semi-automated, three dimensional technique allowing quantification of cerebellar volume and its substructure using MRI. Magn Reson Med 1998; 40:143-151
13. Gibb WRG, Lees AJ. The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease. J Neurol Neurosurg Psychiatry 1988;51:745-752
14. Ward CD, Gibb WR. Research diagnostic criteria for Parkinson's disease. Adv Neurol 1990;53:245-249
15. Quinn N. Multiple system atrophy - the nature of the beast. J Neurol Neurosurg Psychiatry 1989;52(Suppl):78-89
16. Litvan I, Agid Y, Jankovic J, et al. Accuracy of clinical criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome). Neurology 1996;46:922-930
17. Welte D, UK, Skalej M, Kolb R, et al. Quantifizierung des Fehlers von Volumenbestimmungen in der Kernspintomographie mit Hilfe von Agarose-Phantomen. Z Med Phys 1995;5: 208-215
18. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J Am Stat Assoc 1955;50: 1096-1121
19. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 1992; 55:181-184
20. Aylward EH, Brandt J, Codori AM, et al. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology 1994;44:823-828
21. Aylward EH, Codori A-M, Barta PE, et al. Basal ganglia volume and proximity to onset in presymptomatic Huntington disease. Arch Neurol 1996;53:1293-1296
22. Aylward EH, Li Q, Stine OC, et al. Longitudinal change in basal ganglia volume in patients with Huntington's disease. Neurology 1997;48:394-399
23. Hillman GR, Kent TA, Kaye A, et al. Measurement of brain compartment volumes in MR using voxel composition calculations. J Comp Assist Tomogr 1991;15:640-646
24. Luef G, Burtscher J, Kremser C, et al. Magnetic resonance volumetry of the cerebellum in epileptic patients after phenytoin overdosages. Eur Neurol 1996;36:273-277
25. Aylward EH, Habbak R, Warren AC, et al. Cerebellar volume in adults with Down syndrome. Arch Neurol 1997;54:209-212
26. Raz N. Neuroanatomy of the aging brain observed in vivo. In: Bigler ED, ed. Neuroimaging II: clinical applications. New York: Plenum Press, 1996:153-182
27. Raz N, Dupuis JH, Briggs SD, et al. Differential effects of age and sex on the cerebellar hemispheres and the vermis: a prospective MR study. Am J Neuroradiol 1998;19:65-71
28. Ellis RS. Norms of structural in human cerebellum from birth to old age. J Comp Neurol 1920;32:1-33
29. DeCarli C, Murphy DGM, Gillette JA, et al. Lack of age-related differences in temporal lobe volume of very healthy adults. Am J Neuroradiol 1994;15:689-696
30. Blatter DD, Bigler ED, Gale SD, et al. Quantitative volumetric analysis of brain MR: normative database spanning 5 decades of life. Am J Neuroradiol 1993;16:241-251
31. Matsumae M, Kikinis R, Morocz IA, et al. Age-related changes in intracranial compartment volumes in normal adults assessed by magnetic resonance imaging. J Neurosurg 1996;84:982-991
32. Jack CR Jr, Petersen RC, Xu YC, et al. Medial temporal atrophy on MRI in normal aging and very mild Alzheimer's disease. Neurology 1997;49:786-794
33. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. J Neurol Neurosurg Psychiatry 1969;32:28-34
34. Fearnley JM, Lees AJ. Striatonigral degeneration. A clinicopathological study. Brain 1990;113:1823-1842
35. Quinn N. Multiple system atrophy. In: Marsden CD, Fahn S, eds. Movement disorders 3. Oxford: Butterworth-Heinemann, 1994:262-281
36. Otsuka M, Ichiya Y, Kuwabara Y, et al. Glucose metabolism in the cortical and subcortical brain structures in multiple system atrophy and Parkinson's disease: a positron emission tomographic study. J Neurol Sci 1996;144:77-83
37. Gilman S, St Laurent RT, Koeppe RA, et al. A comparison of cerebral blood flow and glucose metabolism in olivopontocerebellar atrophy using PET. Neurology 1995;45:1345-1352
38. Perani D, Bressi S, Testa D, et al. Clinical/metabolic correlations in multiple system atrophy. Arch Neurol 1995;52:179-185
39. Daniel SE, de Bruin VMS, Lees AJ. The clinical and pathological spectrum of Steele-Richardson-Olszewski syndrome (progressive supranuclear palsy): a reappraisal. Brain 1995;118:759-770
40. Probst A, Luginbühl M, Langui D, et al. Pathology of the striatum in progressive supranuclear palsy: abnormal tau proteins in astrocytes and cholinergic interneurons. Neurodegeneration 1993;2:183-193
41. Fox NC, Warrington EK, Freeborough PA, et al. Presymptomatic hippocampal atrophy in Alzheimer's disease. Brain 1996; 119:2001-2007
42. Fox NC, Freeborough PA, Rossor MN. Visualisation and quantification of rates of atrophy in Alzheimer's disease. Lancet 1996;348:94-97